
    
      Since influenza vaccination is recommended in the age range of the study population, Fluarixâ„¢
      (GlaxoSmithKline Biologicals) vaccine will be offered free of charge during the study period
      (for 3 consecutive years starting from September 2004), to be used by Investigators according
      to national vaccination schedule/practice.

      The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep
      2007.
    
  